* TG Therapeutics Inc. Amends genuine phase 3 clinical trial
to accelerate study completion by revising primary endpoint to
overall response rate
The post BRIEF-TG Therapeutics amends phase 3 clinical trial appeared first on NASDAQ.
Forex – financial instrument.Forex news
* TG Therapeutics Inc. Amends genuine phase 3 clinical trial
to accelerate study completion by revising primary endpoint to
overall response rate
The post BRIEF-TG Therapeutics amends phase 3 clinical trial appeared first on NASDAQ.